The Complete Guide to the Griffith Weight Study: Benefits, Brain Impacts, and What Patients Must Know
Systemic adiposity acts as a persistent inflammatory engine. Visceral fat cells secrete interleukins and tumor necrosis factor-alpha (TNF-α), compounds that cross the blood-brain barrier to trigger chronic neuroinflammation. Over months of steady mass reduction, the trial documented a 41% decline in high-sensitivity C-reactive protein (hs-CRP), accompanied by heightened levels of brain-derived neurotrophic factor (BDNF).
Patients demonstrated measurable gains in cognitive function, specifically working memory, processing speed, and sustained attention during computer-based neurocognitive batteries. Researchers hypothesize that eliminating cerebral microvascular stress directly drives these neuroprotective effects. The brain functions far more efficiently when it is spared the constant glucose oscillations and vascular inflammation that characterize advanced metabolic dysfunction.